Navigation Links
NDO Receives FDA 510(K) Clearance for Plicator II(TM)
Date:9/22/2007

tudy represent an improvement over previously reported treatment outcomes using a single implant treatment technique with improved outcomes achieved in a more difficult to treat patient population.

About NDO Surgical

Based in Mansfield, Mass., NDO Surgical, Inc. (NDO) is a leader in flexible endoscopic technologies that enable surgical procedures through the body's natural openings. The company's first product, the Plicator, treats gastroesophageal reflux disease (GERD), a debilitating condition that affects 15M Americans. The Plicator is also the leading gastric closure device for Natural Orifice Translumenal Endoscopic Surgery (NOTES) research procedures. Investors include Versant Ventures, Polaris Ventures, and Menlo Ventures. Additional information is available at the Company's website at http://www.ndosurgical.com.


'/>"/>
SOURCE NDO Surgical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 16, 2014 Paradigm Physical Therapy is ... new therapeutic treatment for their patients. Dry needling is ... a variety of musculoskeletal problems. , In this invasive ... into the skin and muscle to create a trigger ... the needle helps to deactivate and release the trigger ...
(Date:9/16/2014)... Wearable electronic activity monitors hold great promise in ... goals. These increasingly sophisticated devices help the wearers ... and bodily responses. This information is organized into ... Given the large and quickly growing market for ... Medical Branch at Galveston analyzed 13 of these ...
(Date:9/16/2014)... DC September 14, 2014 A ... everolimus-eluting stents (EES) and drug-eluting balloons (DEB) ... stents found that EES provided superior late ... , Findings were reported today at ... scientific symposium. Sponsored by the Cardiovascular Research ...
(Date:9/16/2014)... September 16, 2014 Seven heroes who ... world will be honored in New York City on ... ), the only global recognition and funding program that ... by the media as the “Nobel Prize for Child ... created life-changing programs that benefit children in countries around ...
(Date:9/16/2014)... HealthDay Reporter TUESDAY, Sept. ... the first objective scientific way to diagnose major depression in ... levels of nine genetic indicators (known as "RNA markers") in ... respond to cognitive behavioral therapy, one of the most common ... therapy worked, Northwestern University researchers report. Depression affects nearly ...
Breaking Medicine News(10 mins):Health News:Paradigm Physical Therapy Introduces Dry Needling 2Health News:Do wearable lifestyle activity monitors really work? 2Health News:Do wearable lifestyle activity monitors really work? 3Health News:Results of RIBS IV trial reported at TCT 2014 2Health News:World of Children® Award Announces 2014 Honorees 2Health News:World of Children® Award Announces 2014 Honorees 3Health News:World of Children® Award Announces 2014 Honorees 4Health News:World of Children® Award Announces 2014 Honorees 5Health News:World of Children® Award Announces 2014 Honorees 6Health News:World of Children® Award Announces 2014 Honorees 7Health News:World of Children® Award Announces 2014 Honorees 8Health News:Blood Test Spots Adult Depression: Study 2Health News:Blood Test Spots Adult Depression: Study 3
... ... not friendly one-on-one conversation. , ... New York, NY (PRWEB) November 18, 2009 -- A new national ... e-patients to “friend” them on Facebook. Instead, health organizations would be better off ...
... Young football ... sustain a series of even small head bumps may be at increased risk of long-term brain ... Boston (Vocus) November 19, 2009 ... But players who sustain a series of even small head bumps may be at increased risk ...
... Plavix bested by latest anti-clotting alternatives , WEDNESDAY, Nov. ... three new trials suggest that the latest generation of ... clopidogrel (Plavix). , In one study, dabigatran etexilate (marketed ... is not yet approved in the United States) proved ...
... Preliminary report from the Harvard School of Public Health reveals students ... Think your kids won,t eat healthy foods? Think again. A preliminary ... of Public Health, funded by Project Bread, proves that kids not ... healthy foods than they would if they were eating a traditional ...
... Calif., Nov. 18 Endologix, Inc. (Nasdaq: ... aortic disorders, announced today that it has received ... United States Food and Drug Administration ("FDA") to ... a bilateral percutaneous approach to endovascular abdominal aortic ...
... announces the November 2009 publication of a special ... devoted to residential design for persons with neurodisability. ... of the long-term living environment can improve quality ... who are cognitively, behaviorally and/or physically challenged due ...
Cached Medicine News:Health News:Older E-Patients Prefer Facts, Not Friendship from Health Organizations Communicating Via Social Media, According to Path of the Blue Eye Project Survey 2Health News:Throw a Yellow Flag on Football-related Head Injuries, Warns the Harvard Mental Health Letter 2Health News:Newer Blood Thinners May Outperform Old Standbys 2Health News:Newer Blood Thinners May Outperform Old Standbys 3Health News:New Study Proves Kids Like Eating Healthy Food 2Health News:New Study Proves Kids Like Eating Healthy Food 3Health News:Endologix Receives IDE Approval for Fully Percutaneous Approach to EVAR 2Health News:Endologix Receives IDE Approval for Fully Percutaneous Approach to EVAR 3Health News:Residential design for persons with neurological disability 2Health News:Residential design for persons with neurological disability 3
(Date:9/16/2014)... -- Research and Markets has announced the addition ... to their offering. Animal vaccines are biological ... are generally prepared from weakened or dead microbes that can ... of the animal vaccines are also formulated using a part ... components. These components act as stimulating agents ...
(Date:9/16/2014)... 16, 2014  Advanced Medical Isotope Corporation ... company engaged primarily in the development of ... and therapeutic applications, today announced that a ... its brachytherapy products.  AMIC,s rights for the ... from Battelle, under which AMIC exclusively licensed ...
(Date:9/16/2014)... Sept. 16, 2014 Surgeons at The Children,s ... a case report the first successful use of a ... year-old boy with failing Fontan circulation to bridge him ... 3 years old, the patient received a Fontan circulation ... single ventricle. "The Fontan operation is the final planned ...
Breaking Medicine Technology:Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 413-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3
... - A new study published today,in the ... Survey of,Physician-Industry Relationships") on the extent of ... for,profession-wide and public policy reforms promoted by ... existing,voluntary PhRMA (Pharmaceutical Research and Manufacturers of,America) ...
... NIGUEL, Calif.--(BUSINESS WIRE)--Apr 26, 2007 - Aeolus,Pharmaceuticals, ... April 18, 2007 issue of the Journal ... University of Colorado and National Jewish,Medical and ... available catalytic antioxidant, AEOL 11207, demonstrated,neuroprotection in ...
Cached Medicine Technology:Ties Between Physicians and Drug Companies Still Too Strong: the,Prescription Project Offers Solutions to Prevent Conflicts of,Interest 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3
Seasoned oak cabinet with flat sides and disappearing door...
Slide Sorters for sorting and viewing 5 cm x 5 cm (2 inches x 2 inches) color slides....
It's a slide cabinet system, store up to 54,000 slides in only 2 square feet of space. Ideal for use in Pathology, Cytology, Hematology, Histology, Dermatology, Research, Education....
Individually, self-contained, stackable drawers....
Medicine Products: